PROGRAM MENU
EDUCATIONAL PROGRAM
PRE-SUMMIT WORKSHOPS
SATELLITE SYMPOSIA
Educational Program
THSNA programming is focused on presenting the most current issues in Hemostasis and Thrombosis. THSNA 2022 will include daily plenary sessions (without other concurrent sessions); four educational tracks, a Pre-Summit Workshop Day, daily ePoster sessions, oral abstract presentations of original research and an exhibit hall with commercial booths.
MONDAY, AUGUST 15
|
1:00 - 5:00 PM
EVENT/OTHER
|
INTERESTING CASES IN LABORATORY HEMOSTASIS AND THROMBOSIS Chicago Ballroom IX-X Hosted by NASCOLA and ISLH Interesting and challenging cases in laboratory hemostasis and thrombosis will be presented. Audience participation will be encouraged. |
||||
1:00 |
WELCOME & INTRO FROM ISLH AND NASCOLA. |
|||||
1:10 |
CATHY HAYWARD (ISLH) Cathy Hayward. McMaster University |
|||||
1:30 |
KRISTI SMOCK (NASCOLA) Kristi Smock. University of Utah and ARUP Laboratories |
|||||
1:50 |
PARUL BHARGAVA (ISLH) Parul Bhargava. University of California San Francisco |
|||||
2:10 |
TRISH LOWERY (NASCOLA) Trish Lowery. Tricore Reference Laboratories |
|||||
2:30 |
KATRIEN DEVREESE (ISLH) Katrien Devreese. Ghent University |
|||||
2:50 |
BREAK. |
|||||
3:10 |
NICOLE ZANTEK (NASCOLA) Nicole Zantek. University of Minnesota |
|||||
3:30 |
MARIAN ROLLINS-RAVAL (ISLH) Marian Rollins-Raval. University of New Mexico/Tricore Reference Laboratories |
|||||
3:50 |
ANDREW GOODWIN (NASCOLA) Andrew Goodwin. University of Vermont Larner College of Medicine and the University of Vermont Medical Center |
|||||
4:10 |
KAREN MOSER (ISLH) Karen Moser. University of Utah and ARUP Laboratories |
|||||
4:30 |
JING JIN (NASCOLA) Jing Jin. Stanford University |
|||||
4:50 |
CONCLUDING REMARKS. |
|||||
| |
NURSING WORKSHOP: EFFECTIVE PATIENT CARE - HEALTH LITERACY, EDUCATION AND SHARED DECISION MAKING (THE TRIFECTA) Chair/Organizer: Regina Butler, Terri Schnurr Chicago Ballroom VI Hosted by the THSNA Member Organization Nurses |
||||
1:00 |
WELCOME AND INTRODUCTION Charity Stadler, Regina Butler. |
|||||
1:10 |
HEALTH LITERACY Lisa Littner. Cincinnati Children's Hospital Medical Center |
|||||
1:50 |
CARING FOR PATIENTS ON A/C Jennifer Meldau. Children's National, Washington D. C. |
|||||
2:05 |
MATERIALS FOR EDUCATING PATIENTS/PEERS Jim Munn. Michigan Medicine |
|||||
2:20 |
Q & A. |
|||||
2:35 |
BREAK. |
|||||
2:50 |
DOAC LEVELS: INDICATIONS AND INTERPRETATION Julia Bayadinova. St. Joseph's Healthcare Hamilton |
|||||
3:05 |
SIMPLIFYING PERIOPERATIVE A/C MANAGEMENT Laurie Sardo. St. Joseph's Healthcare Hamilton |
|||||
3:20 |
ITP PATIENTS, COMPREHENSIVE CARE AND GUIDELINES Kristin Ansteatt. Bleeding and Clotting Disorders Institute |
|||||
3:35 |
Q & A. |
|||||
3:50 |
PATIENT EMPOWERMENT Maria Santaella. National Hemophilia Foundation |
|||||
4:05 |
PAEDIATRIC RESEARCH EDUCATION Terri Schnurr. St. Joseph's Healthcare Hamilton |
|||||
4:20 |
PANEL DISCUSSION. |
|||||
|
1:00 - 3:00 PM
EVENT/OTHER
|
PLATELET DISORDER SUPPORT ASSOCIATION WORKSHOP: COVID-19 & ITP: VIRUSES & VACCINES - HOW THEY CAN AFFECT PLATELETS AND CAUSE BLEEDING AND CLOTTING ISSUES Chicago Ballroom VII For individuals living with immune thrombocytopenia (ITP), a rare autoimmune bleeding disorder characterized by low blood platelet counts, COVID-19 caused immediate alarm, as the virus and then the vaccines impacted platelet counts in some patients, causing both bleeding and clotting issues. This program will help you to understand whether the SARS-CoV-2 virus and COVID-19 agents affect platelet counts and bleeding/clotting events to determine if persons with and without pre-existing ITP have risks for adverse events. |
||||
1:00 |
COVID-19 & ITP: VIRUSES & VACCINES - HOW THEY CAN AFFECT PLATELETS AND CAUSE BLEEDING AND CLOTTING ISSUES Michael Tarantino. The Bleeding and Clotting Disorders Institute |
|||||